See the original post here: Chr. Hansen Holding A/S Interim Report Q3 2022/23
See the original post here: Chr. Hansen Holding A/S Interim Report Q3 2022/23
Read the rest here: Zealand Pharma announces positive results from Part 1 of multiple ascending dose trial with amylin analog ZP8396
Read this article: AC Immune Showcasing Precision Medicine Programs at AAIC 2023
See the original post here: MediWound Receives Positive Scientific Advice from European Medicine Agency (EMA) on EscharEx Phase III Study Design
See original here: Krystal Biotech Announces First Patient Dosed in Phase 1 Clinical Trial of KB407 for the Treatment of Cystic Fibrosis
The rest is here: Tonix Pharmaceuticals Completes Acquisition of Two FDA-Approved, Marketed Migraine Products
See the original post here: Fortrea Launches as Leading, Global Contract Research Organization Positioned to Bring Life-Changing Therapies to Patients Faster
Read more: NorthX Biologics, a leading Nordic development and manufacturing organisation announces acquisition of a biologics manufacturing unit from Valneva
Original post: Journey Medical Corporation Expects Topline Results from the Phase 3 Clinical Trials (MVOR-1 and MVOR-2) Evaluating DFD-29 (Minocycline Hydrochloride...
Go here to read the rest: Nevakar Injectables Announces FDA Approval of Cyclophosphamide RTD Solution
Recent Comments